Methoctramine, a polymethylene tetraamine, differentiates three subtypes of muscarinic receptor in direct binding studies
- 1 January 1988
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 145 (1) , 61-66
- https://doi.org/10.1016/0014-2999(88)90349-4
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Differential blockade of muscarinic receptor subtypes by polymethylene tetraamines. Novel class of selective antagonists of cardiac M-2 muscarinic receptorsJournal of Medicinal Chemistry, 1987
- Binding profile of a novel cardioselective muscarine receptor antagonist, AF-DX 116, to membranes of peripheral tissues and brain in the ratLife Sciences, 1986
- A unique regulatory profile and regional distribution of [3H]pirenzepine binding in the rat provide evidence for distinct M1 and M2 muscarinic receptor subtypesLife Sciences, 1983
- DOES PIRENZEPINE DISTINGUISH BETWEEN ‘SUBTYPES’ OF MUSCARINIC RECEPTORS?British Journal of Pharmacology, 1982
- Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterizationLife Sciences, 1982
- [3H]rauwolscine and [3H]yohimbine binding to rat cerebral and human platelet membranes: Possible heterogeneity of α2-adrenoceptorsEuropean Journal of Pharmacology, 1982
- LIGAND: A versatile computerized approach for characterization of ligand-binding systemsAnalytical Biochemistry, 1980
- Pirenzepine distinguishes between different subclasses of muscarinic receptorsNature, 1980
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973
- THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONSAnnals of the New York Academy of Sciences, 1949